DREAM: a multifunctional transcriptional regulator.
- Author:
Zi-Bing FU
1
,
2
,
3
;
Xu-Bo DUAN
1
;
Li-Na LI
1
;
Xiao-Kang LEI
1
;
Ye JIANG
1
;
Chen WANG
1
;
Han-Xiao XU
1
;
Yin-Lian ZHANG
1
;
Jiao-Hua JIANG
1
;
Rui-Chao CHAI
1
;
Xi-Hua JIA
1
;
Albert Cheung Hoi YU
1
;
Author Information
- Publication Type:Journal Article
- From: Acta Physiologica Sinica 2017;69(5):703-714
- CountryChina
- Language:Chinese
- Abstract: DREAM (downstream regulatory element antagonist modulator), Calsenilin and KChIP3 (potassium channel interacting protein 3) belong to the neuronal calcium sensor (NCS) superfamily, which transduces the intracellular calcium signaling into a variety of activities. They are encoded by the same gene locus, but have distinct subcellular locations. DREAM was first found to interact with DRE (downstream regulatory element) site in the vicinity of the promoter of prodynorphin gene to suppress gene transcription. Calcium can disassemble this interaction by binding reversibly to DREAM protein on its four EF-hand motifs. Apart from having calcium dependent DRE site binding, DREAM can also interact with other transcription factors, such as cAMP responsive element binding protein (CREB), CREB-binding protein (CBP) and cAMP responsive element modulator (CREM), by this concerted actions, DREAM extends the gene pool under its control. DREAM is predominantly expressed in central nervous system with its highest level in cerebellum, and accumulating evidence demonstrated that DREAM might play important roles in pain sensitivity. Novel findings have shown that DREAM is also involved in learning and memory processes, Alzheimer's disease and stroke. This mini-review provides a brief introduction of its discovery history and protein structure properties, focusing on the mechanism of DREAM nuclear translocation and gene transcription regulation functions.
